Article
The Lancet  (2011)

Use of secondary prevention drugs for cardiovascular disease in the community in high-income, middle-income, and low-income countries (the PURE Study)=> a prospective epidemiological survey

Yusuf S., Islam; S, Chow; CK, Rangarajan S.; Dagenais G., Díaz R; Gupta R., Kelishadi R.; Iqbal R., Avezum A.; Kruger A., Kutty R.; Lanas F., Liu; LS, Wei L.; Lopez-Jaramillo, P; Oguz A., Rahman O.; Swidan, H; Yusoff K., Zatonski W.; Rosengren A., Teo